Integer (NYSE:ITGR) VP Tommy Thomas Sells 825 Shares

Integer Holdings Corporation (NYSE:ITGRGet Free Report) VP Tommy Thomas sold 825 shares of Integer stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $85.00, for a total transaction of $70,125.00. Following the completion of the sale, the vice president owned 4,381 shares in the company, valued at approximately $372,385. This represents a 15.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Integer Price Performance

NYSE ITGR opened at $87.17 on Wednesday. The company has a 50-day moving average price of $85.44 and a two-hundred day moving average price of $85.38. Integer Holdings Corporation has a 52 week low of $62.00 and a 52 week high of $127.56. The stock has a market cap of $3.00 billion, a price-to-earnings ratio of 30.37, a price-to-earnings-growth ratio of 1.43 and a beta of 0.75. The company has a current ratio of 3.32, a quick ratio of 2.23 and a debt-to-equity ratio of 0.69.

Integer (NYSE:ITGRGet Free Report) last released its quarterly earnings results on Thursday, February 19th. The medical equipment provider reported $1.76 earnings per share for the quarter, beating analysts’ consensus estimates of $1.70 by $0.06. The company had revenue of $472.06 million for the quarter, compared to analysts’ expectations of $462.73 million. Integer had a return on equity of 13.26% and a net margin of 5.55%.The business’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.43 earnings per share. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. Analysts forecast that Integer Holdings Corporation will post 6.01 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. Citigroup boosted their price target on Integer from $75.00 to $92.00 and gave the stock a “neutral” rating in a research report on Friday, February 20th. Truist Financial raised their price target on Integer from $95.00 to $97.00 and gave the company a “buy” rating in a report on Friday, February 20th. Wall Street Zen cut shares of Integer from a “buy” rating to a “hold” rating in a research note on Sunday, January 25th. Wells Fargo & Company upped their price objective on shares of Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a report on Friday, February 20th. Finally, Raymond James Financial reissued an “outperform” rating and set a $101.00 target price on shares of Integer in a research note on Monday, February 23rd. Four research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $102.00.

Check Out Our Latest Stock Report on Integer

Institutional Trading of Integer

Several institutional investors and hedge funds have recently bought and sold shares of ITGR. Corient Private Wealth LLC purchased a new stake in Integer during the fourth quarter valued at about $539,000. T. Rowe Price Investment Management Inc. increased its position in shares of Integer by 800,382.9% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 280,169 shares of the medical equipment provider’s stock worth $21,974,000 after acquiring an additional 280,134 shares in the last quarter. Mercer Global Advisors Inc. ADV increased its position in shares of Integer by 1.4% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 41,049 shares of the medical equipment provider’s stock worth $3,219,000 after acquiring an additional 555 shares in the last quarter. XTX Topco Ltd acquired a new stake in shares of Integer during the fourth quarter valued at approximately $4,581,000. Finally, Voloridge Investment Management LLC purchased a new stake in shares of Integer in the 4th quarter valued at approximately $14,694,000. Institutional investors and hedge funds own 99.29% of the company’s stock.

About Integer

(Get Free Report)

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.

Featured Articles

Insider Buying and Selling by Quarter for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.